 recommended for these purposes (GRADE 2, Level of Evidence A).
4. Anticoagulation is not recommended for the treatment
of TIA or acute stroke, unless there is evidence of a
cardioembolic source (GRADE 1, Level of Evidence B).
5. Antiplatelet therapy in asymptomatic patients with carotid atherosclerosis is recommended to reduce overall
cardiovascular morbidity, although it has not been
shown to be effective in the primary prevention of